We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PerkinElmer Acquires X-Ray Technology Company

By MedImaging International staff writers
Posted on 04 Jul 2011
Print article
PerkinElmer, Inc. (Waltham, MA, USA), a global company focused on the health and safety of people and the environment, announced that it has acquired Dexela, Ltd. (London, UK), a provider of flat panel complementary metal-oxide-semiconductor (CMOS) X-ray detection technologies and services.

The acquisition of Dexela expands PerkinElmer's current medical imaging range in key areas including surgery, dental CT, cardiology, and mammography, as well as nondestructive testing (NDT). With the addition of the CMOS technology to the company's imaging product range, customers will now be able to choose seamlessly between two complementary X-ray detector technologies to optimize their system performance and meet their specific application needs.

Dexela develops and commercializes its CMOS technology portfolio, which includes hardware and software offerings for fast, low-dose X-ray imaging. The company's CMOS products offer high spatial resolution frame rate and effectiveness, low noise, and absence of image lag. The Dexela technology is designed to provide high image quality, whether detecting defects in human tissue or industrial objects and structures, through design-friendly components that can be easily incorporated into an original equipment manufacturer (OEM) instrument or platform.

In addition to its CMOS X-ray detection units, Dexela technologies and services include its Dexela mammography workstation, the DexView image processing software, its three-dimensional (3D) reconstruction engine software, and consulting and implementation services.

"Dexela has been a pioneer in the development of CMOS X-ray detection solutions and has achieved award-winning recognition in the imaging market for its design strengths and ease of manufacturability, which are major advantages for OEM customers," said Brian Giambattista, president, medical imaging, PerkinElmer. "We look forward to expanding the reach of this promising technology into adjacent markets such as surgery, dental CT [computed tomography], cardiology, mammography, and industrial NDT, to detect, monitor, and remediate threats to human health or structural integrity."

Dexela is a developer of innovative technologies for fast, low-dose X-ray imaging. Formed in 2005, Dexela pioneered developments in breast tomosynthesis. In 2009, Dexela launched a family of flat panel CMOS X-ray detectors ideally suited to breast tomosynthesis and a range of other applications including mammography, fluoroscopy, dental cone beam CT (CBCT), cardiology, angiography, and bone densitometry, scientific instrumentation and nondestructive testing.

Related Links:

PerkinElmer
Dexela


40/80-Slice CT System
uCT 528
Radiology Software
DxWorks
Ultra-Flat DR Detector
meX+1717SCC
New
Specimen Radiography System
Trident HD

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.